← Open Payments lookup

MEGAN GREEN: Open Payments

NPI 1548592355 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$799 in 50 payments from 18 companies in 2025. Trend: 2023 $1,014 · 2024 $821 · 2025 $799

Food & beverage: $799
CompanyPaymentsAmount
ABBVIE INC.10$163
Lilly USA, LLC14$143
Novo Nordisk Inc6$106
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$44
Sumitomo Pharma America, Inc.2$42
PFIZER INC.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$38
GlaxoSmithKline, LLC.2$29
Otsuka America Pharmaceutical, Inc.1$24
Corcept Therapeutics1$23

Products named: MOUNJARO, JARDIANCE, Rybelsus, VRAYLAR, QULIPTA, REXULTI, XIFAXAN, GEMTESA.

Industry payments across TX — which companies pay providers there.